CN108126236B - Medicine coating material and preparation method thereof - Google Patents
Medicine coating material and preparation method thereof Download PDFInfo
- Publication number
- CN108126236B CN108126236B CN201711384801.2A CN201711384801A CN108126236B CN 108126236 B CN108126236 B CN 108126236B CN 201711384801 A CN201711384801 A CN 201711384801A CN 108126236 B CN108126236 B CN 108126236B
- Authority
- CN
- China
- Prior art keywords
- parts
- mass
- chitosan
- coating material
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention relates to a medical coating material and a preparation method thereof in the field of medical health. Dissolving 5-30 parts by mass of sodium alginate, 3-20 parts by mass of water-soluble chitosan, 5-50 parts by mass of sodium chloride, 20-100 parts by mass of glycerol and 0-100 parts by mass of propylene glycol in 100-1000 parts by mass of distilled water under stirring to obtain A; adding 50-600 parts by mass of emulsifier and 300-700 parts by mass of siloxane resin into 300-800 parts by mass of volatile siloxane, and uniformly mixing to obtain B; slowly adding the A into the B solution, and emulsifying uniformly to obtain the medicinal coating material. The medical coating material of the invention has the functions of stopping bleeding and accelerating the healing of skin wound; has antibacterial and antibacterial effects, and has strong antibacterial and antibacterial effects on wound surface and external bacteria; can actively and passively moisturize the skin, has hydration effect on scar skin and has good repairing effect.
Description
Technical Field
The invention relates to a medical coating material and a preparation method thereof, belonging to a medical biomaterial in the field of medical health.
Background
At present, the body surface wound, the operation incision and the burned and scalded surface of a human body are generally treated by taking measures of coating and disinfecting gauze, winding a bandage and the like, the gauze is often attached to the wound surface due to blood coagulation, the granulation of the wound is repeatedly damaged when medicines are replaced, the wound healing time is prolonged, the patient can be suffered from pain which is difficult to bear sometimes, and the operation of medical care personnel is troublesome. And the traditional gauze dressing material has the defects of poor air permeability at the wound, difficult large-area use and easy invasion of bacteria.
Alginate is a natural anionic polysaccharide, can form gel after contacting with wound exudate, generates high absorption force by forming strong hydrophilic gel, can lock a large amount of water, and is a good gelling material. Meanwhile, the alginate is used for the metabolism of human bodyHas unique regulating effect, and has effects of relieving inflammation, stopping bleeding, and resolving hard mass. Chitosan is the only natural basic polysaccharide discovered so far, not only has antibacterial and hemostatic functions, but also can prevent the formation of fibrin, the proliferation of connective tissue cells and the synthesis of collagen, thereby minimizing the stagnation after the wound is healed. At C2-NH of chitosan2The water-soluble chitosan is obtained by deriving and introducing acid radical ions, carboxymethyl and quaternary ammonium salt on C6-OH or degrading chitosan into chitosan oligosaccharide, improving deacetylation degree and the like, and the effective-NH of the chitosan is improved3 +The exposure and the permeability of chitosan to cells, and the antibacterial and bacteriostatic activity of the chitosan are also obviously increased.
The chitosan/alginate dressing consisting of water-soluble chitosan and alginate can rapidly absorb exudate and blood after contacting with the exudate and the blood, and forms adhesive gel on the contact surface to be attached to the wound surface. However, the chitosan/alginate dressing has the fatal defects of poor water resistance, strong hygroscopicity, high air permeability and the like because the molecular structure of the chitosan/alginate dressing contains a large number of hydrophilic groups such as hydroxyl groups and the like.
Disclosure of Invention
Aiming at the problems in the prior art, the invention aims to improve the water resistance and the oxygen permeability of the chitosan/sodium alginate dressing by introducing siloxane with the water resistance, high oxygen permeability and scar removing effect. The invention mixes and dissolves sodium alginate and water-soluble chitosan in distilled water at a ratio of 10: 1-1.5: 1, and emulsifies the mixture with siloxane resin, surfactant and volatile siloxane, thereby developing a safe, effective and sprayable quick-acting curing biological liquid adhesive bandage. Alginate can absorb wound exudate; the chitosan can inhibit the adhesion of bacteria and the proliferation of pathogenic microorganisms on the composite dressing, and can reduce the risk of bacterial infection even if the composite dressing is used for a long time; the siloxane resin is breathable and waterproof, and can reduce the water diffusion of the wound and repair scars by sealing and hydrating the skin. The volatile siloxane is volatilized rapidly, and quick-acting curing of the dressing is realized.
The invention discloses a medicine coating material, which is prepared by the following method: dissolving 5-30 parts by mass of sodium alginate, 3-20 parts by mass of water-soluble chitosan, 5-50 parts by mass of sodium chloride, 20-100 parts by mass of glycerol and 0-100 parts by mass of propylene glycol in 100-1000 parts by mass of water under stirring to obtain A; adding 50-600 parts by mass of emulsifier and 300-700 parts by mass of siloxane resin into 300-800 parts by mass of volatile siloxane, and uniformly mixing to obtain B; slowly adding the A into the B solution, and emulsifying uniformly to obtain the medicinal coating material.
Preferably, the water-soluble chitosan is: hyaluronic acid-like chitosan, carboxymethyl chitosan, hydroxypropyl trimethyl ammonium chloride chitosan, chitosan lactate, chitosan hydrochloride, chitosan acetate or chitosan oligosaccharide.
Preferably, the emulsifier is: a water-in-oil emulsifier or a mixed emulsifier of a water-in-oil emulsifier and an oil-in-water emulsifier.
Preferably, the amount of the oil-in-water emulsifier is 1 to 100 parts by mass. The emulsifier is mainly water-in-oil emulsifier, such as span series, and small amount of oil-in-water emulsifier, such as tween series, can be added to adjust the emulsifying capacity of the mixed emulsifier.
Preferably, the silicone resin is trimethylsiloxysilicate, trimethylsiloxysilicate/polypropylsilsesquioxane, acrylate/trimethicone-methacrylate copolymer, trimethylsiloxysilicate/dimethiconol crosspolymer.
Preferably, the volatile silicone has a viscosity of 0.65mpa.s/25 ℃ and a flash point of less than-3 ℃.
Preferably, the emulsification mode is high-speed homogenizing emulsification, mechanical stirring emulsification or grinding emulsification.
The preparation method of the medical coating material comprises the following steps: dissolving 5-30 parts by mass of sodium alginate, 3-20 parts by mass of water-soluble chitosan, 5-50 parts by mass of sodium chloride, 20-100 parts by mass of glycerol and 0-100 parts by mass of propylene glycol in 100-1000 parts by mass of water under stirring to obtain A; adding 50-600 parts by mass of emulsifier and 300-700 parts by mass of siloxane resin into 300-800 parts by mass of volatile siloxane, and uniformly mixing to obtain B; slowly adding the A into the B solution, and emulsifying uniformly to obtain the medicinal coating material.
The emulsified solution is directly sprayed on the wound, and after the solvent is volatilized, a protective layer which can be breathable, waterproof, dustproof, free from the limitation of the shape and the area of the wound and free from the influence on the activity and the cleanness of a patient is formed on the surface of the wound. The product has elasticity and air permeability, is convenient to carry, does not affect the appearance when in use, does not cause uncomfortable feeling, can move freely, is safe and reliable to human body, and has excellent performances of rapidly sealing wound, resisting bacteria, stopping bleeding, promoting healing, removing scar, preventing water and the like. The product is not only suitable for various wounds, but also has special curative effect on certain wounds which are difficult to heal and are clinically troubled for a long time, is more easily accepted by consumers, and has huge market demand.
Detailed Description
The invention is further illustrated by the following specific examples:
example 1
Accurately weighing 20 parts of sodium alginate, 8 parts of chitosan oligosaccharide, 20 parts of sodium chloride and 40 parts of glycerol, and adding 852 parts of distilled water to prepare a light yellow liquid A; weighing 80200 parts of span and 400 parts of trimethylsiloxysilicate, adding 460 parts of hexamethyldisiloxane, stirring and dissolving to obtain B. Slowly adding the solution A into the solution B, homogenizing and emulsifying at high speed for 10min, bottling, and sealing. Directly coated on the surface of the wound, dried and solidified after 30 seconds and has smooth appearance.
Example 2
Accurately weighing 15 parts of sodium alginate, 10 parts of chitosan quaternary ammonium salt, 25 parts of sodium chloride and 20 parts of glycerol, and adding distilled water to 870 parts to prepare light yellow liquid A; weighing 120 parts of Emulsifier10(Dow corning) and 360 parts of acrylate/poly (trimethylsiloxane) -methacrylate copolymer, adding 580 parts of hexamethyldisiloxane, stirring and dissolving to obtain B. Slowly adding the solution A into the solution B, homogenizing and emulsifying at high speed for 10min, bottling, and sealing. Directly coated on the surface of the wound, dried and solidified after 30 seconds and has smooth appearance.
Example 3
Accurately weighing 20 parts of sodium alginate, 5 parts of hyaluronic acid-like chitosan, 20 parts of sodium chloride, 40 parts of glycerol and 20 parts of propylene glycol, and adding 1035 parts of distilled water to prepare light yellow liquid A; weighing 8050 parts of span, 8010 parts of tween and 300 parts of trimethylsiloxysilicate, adding 500 parts of hexamethyldisiloxane, stirring and dissolving to obtain B. Slowly adding the solution A into the solution B, homogenizing and emulsifying at high speed for 10min, bottling, and sealing. Directly coated on the surface of the wound, dried and solidified after 45 seconds, and has smooth appearance.
Example 4
Accurately weighing 10 parts of sodium alginate, 20 parts of chitosan oligosaccharide, 8 parts of sodium chloride, 40 parts of glycerol and 60 parts of propylene glycol, and adding distilled water to 220 parts to prepare light yellow liquid A; 482 parts of Emulsifier10(Dow burning) and 400 parts of trimethylsiloxysilicate are weighed, and 760 parts of hexamethyldisiloxane are added and stirred to dissolve the mixture to obtain B. Slowly adding the solution A into the solution B, homogenizing and emulsifying at high speed for 10min, bottling, and sealing. Spraying 15-20 cm away from the wound, drying and solidifying after 30 seconds, and having smooth appearance.
Example 5
Accurately weighing 5 parts of sodium alginate, 5 parts of carboxymethyl chitosan, 10 parts of sodium chloride, 40 parts of glycerol and 60 parts of propylene glycol, and adding distilled water to 240 parts to prepare light yellow liquid A; 450 parts of Emulsifier10(Dow burning) and 440 parts of trimethylsiloxysilicate/polypropylsilsesquioxane are weighed, 750 parts of hexamethyldisiloxane are added, and stirring and dissolving are carried out, thus obtaining B. Slowly adding the solution A into the solution B, homogenizing and emulsifying at high speed for 10min, bottling, and sealing. Spraying 15-20 cm away from the wound, drying and solidifying after 30 seconds, and having smooth appearance.
The coating material of the invention has good bacteriostatic effect, and the experimental result is as follows:
note: "+" indicates colonies growing and "-" indicates no colonies growing.
Finally, it should also be noted that the above list is only a specific implementation example of the present invention. It is obvious that the invention is not limited to the above embodiment examples, but that many variations are possible. All modifications which can be derived or suggested by a person skilled in the art from the disclosure of the present invention are to be considered within the scope of the invention.
Claims (5)
1. A medical coating material characterized by being produced by the following method: dissolving 5-30 parts by mass of sodium alginate, 3-20 parts by mass of water-soluble chitosan, 5-50 parts by mass of sodium chloride, 20-100 parts by mass of glycerol and 0-100 parts by mass of propylene glycol in 100-1000 parts by mass of water under stirring to obtain A; adding 50-600 parts by mass of emulsifier and 300-700 parts by mass of siloxane resin into 300-800 parts by mass of volatile siloxane, and uniformly mixing to obtain B; slowly adding the A into the B solution, and emulsifying uniformly to obtain a medical coating material;
the siloxane resin is trimethylsiloxysilicate, trimethylsiloxysilicate/polypropylsilsesquioxane, acrylate/trimethicone-methacrylate copolymer, trimethylsiloxysilicate/dimethiconol cross-linked polymer;
the viscosity of the volatile siloxane is 0.65mPa.s/25 ℃, and the flash point is lower than-3 ℃.
2. A medical coating material according to claim 1, wherein said water-soluble chitosan is: hyaluronic acid-like chitosan, carboxymethyl chitosan, hydroxypropyl trimethyl ammonium chloride chitosan, chitosan lactate, chitosan hydrochloride, chitosan acetate or chitosan oligosaccharide.
3. A medical coating material according to claim 1, wherein said emulsifier is: a water-in-oil emulsifier or a mixed emulsifier of a water-in-oil emulsifier and an oil-in-water emulsifier.
4. A medical coating material according to claim 3, wherein the oil-in-water type emulsifier is used in an amount of 1 to 100 parts by mass.
5. A medical coating material according to claim 1, wherein the emulsification is high speed homogeneous emulsification, mechanical agitation emulsification or grinding emulsification.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711384801.2A CN108126236B (en) | 2017-12-20 | 2017-12-20 | Medicine coating material and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711384801.2A CN108126236B (en) | 2017-12-20 | 2017-12-20 | Medicine coating material and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108126236A CN108126236A (en) | 2018-06-08 |
CN108126236B true CN108126236B (en) | 2021-01-01 |
Family
ID=62390881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711384801.2A Active CN108126236B (en) | 2017-12-20 | 2017-12-20 | Medicine coating material and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108126236B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109331219A (en) * | 2018-11-30 | 2019-02-15 | 广州润虹医药科技股份有限公司 | A kind of chitosan liquid dressing |
CN109875957B (en) * | 2019-04-09 | 2022-09-16 | 海默斯(重庆)医学生物技术有限公司 | Skin wound nursing ointment and preparation method thereof |
CN113041023A (en) * | 2021-03-12 | 2021-06-29 | 南昌智产科技有限公司 | Anti-adhesion healing-promoting alginate dressing and preparation method thereof |
CN115591008A (en) * | 2021-12-31 | 2023-01-13 | 上海炫鑫医药科技有限公司(Cn) | Spray-type liquid wound-protecting dressing and preparation method thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001271922A1 (en) * | 2000-07-07 | 2002-01-21 | Collaborative Technologies, Inc. | Method for preparing topical preparations containing skin protective agents withenhanced barrier properties |
JP2007509954A (en) * | 2003-10-27 | 2007-04-19 | ダウ コーニング コーポレーション | Sustained release compositions for topical application and methods of delivering active agents to a substrate |
US7318937B2 (en) * | 2005-03-18 | 2008-01-15 | Closure Medical Corporation | Liquid coating compositions |
CN102008757A (en) * | 2010-12-07 | 2011-04-13 | 天津嘉氏堂科技有限公司 | Scar repair material |
US9579388B2 (en) * | 2012-11-29 | 2017-02-28 | Rene Gauthier | System and method for alleviating the appearance of scars and/or scar tissue |
KR101457789B1 (en) * | 2013-02-13 | 2014-11-03 | 동아제약 주식회사 | Film-forming pharmaceutical compositions for wound treatment and the production method thereof |
CN103467771B (en) * | 2013-09-23 | 2016-03-16 | 潍坊美赫曼生物医药科技有限公司 | A kind of preparation method and its usage of marine bioactivity bleeding-stopping dressing |
-
2017
- 2017-12-20 CN CN201711384801.2A patent/CN108126236B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN108126236A (en) | 2018-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108126236B (en) | Medicine coating material and preparation method thereof | |
CN108014366B (en) | Marine biological material composite hydrogel dressing and preparation method thereof | |
CN103520764B (en) | Functional dressing, and preparation method and application thereof | |
AU2008308849B2 (en) | Silicone gel-based compositions for wound healing and scar reduction | |
CN102258801B (en) | Sponge calcium alginate medical dressing, and preparation method | |
CN103394116B (en) | Hydrogel dressing capable of promoting wound healing and preparation method thereof | |
Shyna et al. | A nonadherent chitosan-polyvinyl alcohol absorbent wound dressing prepared via controlled freeze-dry technology | |
CN105664238A (en) | Preparation method and application of zwitterion water gel dressing | |
CN105012228A (en) | Hyaluronic acid and silica gel composition for scar prevention and early repair and preparation method of hyaluronic acid and silica gel composition | |
CN103494668A (en) | Medical hydrogel moisturizing eye care mask and preparation method thereof | |
CN107899003B (en) | Chitosan oligosaccharide medical wound care membrane and preparation method thereof | |
CN106377791A (en) | Bamboo alginate functional dressing and preparation method thereof | |
CN111481735A (en) | Medical antibacterial wound-protecting hydrogel dressing and preparation method thereof | |
Cook et al. | Hydrogels for the management of second-degree burns: Currently available options and future promise | |
CN105288700A (en) | Medical thermo-sensitive hydrogel dressing and preparation method thereof | |
CN114099476A (en) | Functional gel layer, scar patch and preparation method thereof | |
Burd | Evaluating the use of hydrogel sheet dressings in comprehensive burn wound care | |
CN106110369A (en) | A kind of medical composite type hyaluronic acid dressing and preparation method thereof | |
CN106267316B (en) | Anti- dehydration gecko hydrogel application of one kind and preparation method thereof | |
CN112870430B (en) | Composite gel hemostatic powder based on natural polysaccharide, and preparation method and application thereof | |
CN110876814A (en) | Liquid band-aid rich in antibacterial peptide and preparation method thereof | |
CN112891615B (en) | Liquid adhesive bandage and preparation method thereof | |
CN104382843B (en) | A kind of skin repair gel | |
ZA200404832B (en) | Preparation for wound healing and prevention of bandage adhesion to the wound. | |
CN106540315B (en) | Preparation method of spray-type chitosan aqueous wound dressing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |